Parkinson Disease

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

Movement Disorders
Movement Disorders
FDA Approves New Add-on Therapy for Parkinson Disease
08/28/2019
After 4 clinical trials showed the treatment decreased daily “off” time, the FDA approved this new add-on therapy for adults with Parkinson disease.
08/28/2019
Parkinson Disease
Parkinson Disease
FDA Approves First Treatment for Therapy-Induced Dyskinesia
08/25/2017
The FDA has approved the first and only treatment option for levodopa-induced dyskinesia in patients with Parkinson disease.
08/25/2017
Parkinson Disease
Parkinson Disease
FDA Approves Add-On Treatment for Parkinson Disease
03/21/2017
The FDA has approved Xadago, an add-on treatment for patients with Parkinson disease who experience “off” episodes.
03/21/2017